Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Type
ArticleAuthor/s
Tadolini, MarinaCodecasa, Luigi Ruffo
García-García, José-María
Blanc, François-Xavier
Borisov, Sergey
Alffenaar, Jan-Willem
Andréjak, Claire
Bachez, Pierre
Bart, Pierre-Alexandre
Belilovski, Evgeny
Cardoso-Landivar, José
Centis, Rosella
D'Ambrosio, Lia
De Souza-Galvão, María-Luiza
Dominguez-Castellano, Angel
Dourmane, Samir
Jachym, Mathilde Fréchet
Froissart, Antoine
Giacomet, Vania
Goletti, Delia
Grard, Soazic
Gualano, Gina
Izadifar, Armine
Le Du, Damien
Royo, Margarita Marín
Mazza-Stalder, Jesica
Motta, Ilaria
Ong, Catherine Wei Min
Palmieri, Fabrizio
Rivière, Frédéric
Rodrigo, Teresa
Rossato Silva, Denise
Sánchez-Montalvá, Adrián
Saporiti, Matteo
Scarpellini, Paolo
Schlemmer, Frédéric
Spanevello, Antonio
Sumarokova, Elena
Tabernero, Eva
Tambyah, Paul Anantharajah
Tiberi, Simon
Torre, Alessandro
Visca, Dina
Murguiondo, Miguel Zabaleta
Sotgiu, Giovanni
Migliori, Giovanni Battista
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread, clinical severity, high mortality rate, and capacity to overwhelm healthcare systems. SARS-CoV-2 transmission occurs mainly through droplets, although surface contamination contributes and debate continues on aerosol transmissionThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread, clinical severity, high mortality rate, and capacity to overwhelm healthcare systems. SARS-CoV-2 transmission occurs mainly through droplets, although surface contamination contributes and debate continues on aerosol transmission
See less
See less
Date
2020Share